XLO XILIO THERAPEUTICS INC Other Situations 8-K Filing 2023 - Phase 1 Clinical Trial Data Announcement Xilio Therapeutics, Inc. announced additional data from its Phase 1 clinical trial for XTX101 in patients with advanced solid tumors.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC